BioSpace13d
FDA Still Undecided About Shortage Status of Lilly’s Tirzepatide
Pending the FDA’s decision, compounding pharmacies will remain free to make and market versions of the blockbuster ...
health.wusf.usf.edu15d
Drugmakers and pharmacists battle over who gets to make obesity drugs
Novo Nordisk and Eli Lilly are moving to end compounding of their medicines for good. They say they are no longer in ...
Reuters22d
Eli Lilly's weight-loss drug helps nearly 99% of patients remain diabetes-free
Eli Lilly and rival Novo Nordisk have been testing their drugs for conditions beyond obesity and diabetes. The U.S. Food and Drug Administration is set to decide on the use of Lilly's ...
BioSpace9d
Legal Challenge Over Lilly’s GLP-1 Shortages Highlights FDA’s Post-Chevron Vulnerability
Currently, Eli Lilly’s GLP-1 drugs Mounjaro and Zepbound (tirzepatide) are not on the FDA’s shortage list but compounded ...
NBC 10 Philadelphia16d
Healthy Returns: Eli Lilly's cholesterol pill impresses in mid-stage trial
The treatment demonstrates the diversity of Eli Lilly's drug pipeline beyond its top-selling weight loss and diabetes treatments ... There are currently no approved treatments to lower Lp ...
Reuters10d
Eli Lilly And Co
Eli Lilly's weight-loss drug helps nearly 99% of patients remain diabetes-free Future of Healthcategory· November 13, 2024 Amgen said on Wednesday there was no link between its experimental ...
The Motley Fool25d
1 Stubborn Cloud and 2 Silver Linings for Eli Lilly Stock
Eli Lilly's weight loss drug sales in Q3 weren't as strong as it anticipated. Its earnings will continue to grow at a rapid pace regardless. It still has a couple of levers it can pull to ...
Yahoo1mon
Microdosing Ozempic? Why some people are playing doctor with weight-loss drugs
No matter the drug, microdosing is an inexact art. The weight-loss drug users and doctors ... Administration announced that the shortage of Eli Lilly's Zepbound was over, though Wegovy ...